Neurological disorders

Stem cells in the treatment of neurological disorders

With improvements in detection protocols, doctor training and equipment, as well as our sedentary lifestyles, has led to a substantial raise in detection of neurological disorders.

Doctors now see more and more younger patients who present symptoms similar to people in their 50s and 60s.

Unfortunately, despite our advances, many people still continue to ignore their problems until it’s too late and their disease is either in persistent, chronic state or terminal. The longer the disease is allowed to progress, less chances there are for full recovery.

Short info about neurological disorders

According to The World Health Organization, around 1 billion people in the world are affected by neurological disorders of various severity: from usual migraines and headaches to epilepsy and dementia.

The WHO report “Neurological Disorders: Public Health Challenges”, published in 2006, cites 24.3 million as the number of people worldwide currently suffering from Alzheimer’s disease and other types of neurodegenerative disorders.

In 2017 the WHO has updated the number and cites it at 29.8 million. It is expected to reach 50 to 55 million by 2026. Experts suggest that the majority of new cases will be diagnosed in developing countries.

Another major neurological disorder, epilepsy, is currently affecting 40 to 50 million people across the world.

Various neurological disorders also are the second leading cause of mortality. The group, which includes disorders like M.S., stroke, Parkinson’s disease etc.) now claims almost 10 million people every year, according to the 2015 estimates by Global Burden of Disease Study program.

While conventional medical treatments of neurological disorders have improved, they’re still unable to halt the increasing trend of mortality and disability, which is why many medical professionals and researchers (including us) have turned to stem cells and stem cell-based treatments.

Stem cell-based treatments are representatives of a new approach to medical and biotech industries, being often called “personalized medicine” for how they are tailored for every situation.

Given that neurology studies all disorders and violations, related to the human nervous system, the list of such diseases is extremely long.

Autologous stem cell-based therapy should be considered for the following disorders:

Myopathies:

  1. Polymyositis
  2. Dermatomyositis
  3. Autoimmune myopathy
  4. Systemic lupus erythematosus (SLE)
  5. Rheumatoid arthritis (RA),
  6. Rheumatism,
  7. Polyarteritis nodosa
  8. Focal myositis
  • Multiple sclerosis
  • Amyotrophic lateral sclerosis and ABC syndrome
  • Guillain-Barre syndrome in a recovery stage
  • Encephalopathy (discirculatory, metabolic, toxic…)
  • Recuperation after a stroke
  • Recovery period after acute infectious diseases of the brain and/or spinal cord
  • Osteochondrosis complicated by spinal disc herniation, spinal disc herniation with painful, dystrophic syndromes (cervicalgia, cervicobrachialgia, thoracalgia, lumbodynia, lumbodynia, coccygodynia…)
  • Compression neuropathies (carpal tunnel syndrome, ulnar nerve neuropathy, radial nerve neuropathy, femoral nerve neuropathy, peroneal nerve neuropathy)
  • Non-compression neuropathies (cranial neuropathy, ocular neuropathy
  • Neuralgias (trigeminal, occipital, etc.)
  • Plexopathies (brachial, lumbosacral)
  • Polyneuropathy
  • Parkinson’s disease
  • Spinal cord injury
  • Syringomyelia
  • Craniocerebral injury
  • Restless leg syndrome
  • Chronic fatigue syndrome
  • Neurological disorders in somatic diseases and poisonings